Running Boosts Brain Cells in A-T Mutated Mice

Researchers at the Salk Institute for Biological Studies in La Jolla, Calif., have shown that running can boost brain-cell survival in mice with the neurodegenerative disorder Ataxia-telangiectasia (A-T).1 Surprisingly, during the course of the study, they also discovered that the Atm gene--which is absent in those with the disease--appears to play a critical role in neural stem cell development. A-T is a rare disease characterized by the death of brain cells, which results in a progressive lo

Written byA. J. S. Rayl
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A-T is a rare disease characterized by the death of brain cells, which results in a progressive loss of motor control that typically, by adolescence, confines patients to wheelchairs. While the cell death appears first in the cerebellum, the brain region that directs movement, it eventually occurs throughout the brain.

Courtesy of JThe Salk Institute

Carrolee Barlow

By monitoring the number of revolutions each mouse lapped on a running wheel that was placed in its cage, the researchers actually discovered that the miles logged by these mice appeared to correlate directly with increased cell numbers. "We were stunned by that," says Salk assistant professor Carrolee Barlow, the study's lead author. "It's almost as if they were wearing pedometers, and those that ran more grew more cells," she says.

In the sedentary A-T mice, however, the team found that most newly born brain cells died. "We don't understand that fully, but it ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies